A recent clinical trial on the bad cholesterol-lowering drug Zetia was stopped early after scientists found that a combination of this drug and a statin was less effective at reducing cholesterol buildup in the arteries than a combo of a statin and Niaspan, a drug that raises good cholesterol. Experts say this study shows clear evidence that using niacin drugs such as Niaspan to raise good cholesterol in combination with a statin is a superior treatment to adding Zetia to standard statin treatment.
Read full story >